Servicio de Oftalmologia Oncologica

Cabeza, Peru

Servicio de Oftalmologia Oncologica

Cabeza, Peru
SEARCH FILTERS
Time filter
Source Type

Cruzado-Sanchez D.,Servicio de Oftalmologia Oncologica | Salas-Diaz M.,Federico Villarreal National University | Tellez W.A.,Federico Villarreal National University | Alvarez-Matos S.E.,Federico Villarreal National University | Serpa-Frias S.,Servicio de Oftalmologia Oncologica
Archivos de la Sociedad Espanola de Oftalmologia | Year: 2016

Case report: A 35 year-old male patient with a history of HIV infection characterized by progressive tumour growth in bulbar conjunctiva of the left eye, corresponding to conjunctival squamous cell carcinoma that responded to treatment with interferon alpha-2a. Discussion: Interferon alpha-2b has been used at conjunctival level as a topical immunomodulator treatment, with complete remission of epithelial neoplasms being observed. However, there have not been any previous publications on the use of interferon alpha-2a, which differs from interferon alpha-2b in a single amino acid, for the treatment of conjunctival squamous cell carcinoma. © 2017 Sociedad Española de Oftalmología.

Loading Servicio de Oftalmologia Oncologica collaborators
Loading Servicio de Oftalmologia Oncologica collaborators